Please login to the form below
Shionogi
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Shionogi's 2012 Japan sales performance.
Orphan drugs in latest CHMP recommendations
Shionogi, MSD, Genzyme and Teva. Other drugs recommended by the CHMP included Shionogi's Senshio (ospemifene), which received a positive opinion for the treatment of vulvar and vaginal atrophy, and
Nexium windfall lifts AZ in third quarter
The latter will pay $325m upfront to acquire the global rights to Myalept, subject to an existing distributor licence with Shionogi covering Japan, South Korea, and Taiwan.
Dive in: gaining leadership in a therapeutic area
on the experience of its landmark ViiV joint venture, created with Pfizer in 2009 to focus on HIV, and expanded in 2010 to include Shionogi.
ViiV bags US approval for HIV blockbuster-in-waiting
ViiV is already riding high at the moment as it rolls out Tivicay in the US, Europe and Japan, which helped sales for the joint venture between GlaxoSmithKline, Pfizer and Shionogi
Biosimilar Lantus leads CHMP opinions
ViiV Healthcare, a joint venture between GlaxoSmithKline, Pfizer and Shionogi, also scored a recommendation in infectious diseases.
[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 17 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Pfizer reports positive results for elranatamab in multiple myeloma
- BMS presents positive four-year results for Opdivo combination in lung cancer
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- AstraZeneca shares positive phase 3 results for Tagrisso in lung cancer
- Merck sues US government over Medicare drug price negotiation programme
- How to Increase Engagement During Virtual Events
- AstraZeneca to stop post-marketing study of Andexxa following early success
- Janssen shares positive phase 3 results for erdafitinib in bladder cancer
- Generative AI is coming for healthcare
- Merck sues US government over Medicare drug price negotiation programme
- GSK’s RSV vaccine approved by European Commission for older adults
No results were found
PMHub
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....
Latest intelligence
- The 17th World Congress on Controversies in Neurology
- This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
- Tuberculosis – why it remains a major global public health challenge
- Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
